![C. DOUGADOS | Directrice de Recherches CNRS | PhD in Astrophysics Paris 7 | Université Grenoble Alpes, Grenoble | Department of Physics | Research profile C. DOUGADOS | Directrice de Recherches CNRS | PhD in Astrophysics Paris 7 | Université Grenoble Alpes, Grenoble | Department of Physics | Research profile](https://i1.rgstatic.net/ii/profile.image/438409886998529-1481536470741_Q512/C-Dougados.jpg)
C. DOUGADOS | Directrice de Recherches CNRS | PhD in Astrophysics Paris 7 | Université Grenoble Alpes, Grenoble | Department of Physics | Research profile
PROLONGED EFFECTS OF 3 WEEK THERAPY IN A SPA RESORT ON LUMBAR SPINE, KNEE AND HIP OSTEOARTHRITIS: FOLLOW-UP AFTER 6 MONTHS. A RA
![Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology - The Rheumatologist Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology - The Rheumatologist](https://www.the-rheumatologist.org/wp-content/uploads/springboard/image/THR_2013_09_pp56_02.jpg)
Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology - The Rheumatologist
PUBLIKATIONSVERZEICHNIS (CHRONOLOGISCH) – CHEFARZT DR. FRANK HELDMANN, KLINIK FÜR RHEUMATOLOGIE 1: Erler A, Fiedler J, Koch A
![PDF) Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: The ACT-RAY study PDF) Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: The ACT-RAY study](https://i1.rgstatic.net/publication/259959866_Clinical_radiographic_and_immunogenic_effects_after_1_year_of_tocilizumab-based_treatment_strategies_in_rheumatoid_arthritis_The_ACT-RAY_study/links/0c96053c5a9a2307ea000000/largepreview.png)
PDF) Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: The ACT-RAY study
Association between individual and country-level socioeconomic factors and work participation in spondyloarthritis including pso
![SciELO - Brasil - Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis SciELO - Brasil - Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis](https://minio.scielo.br/documentstore/2523-3106/zTnxV673xLndRpccyZYK5cd/2f53cbf0842ec4f3c647f58ab9b7bbec79a8bf59.png)
SciELO - Brasil - Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis
![PDF) Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial PDF) Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial](https://i1.rgstatic.net/publication/262679839_Symptomatic_Efficacy_of_Etanercept_and_Its_Effects_on_Objective_Signs_of_Inflammation_in_Early_Nonradiographic_Axial_Spondyloarthritis_A_Multicenter_Randomized_Double-Blind_Placebo-Controlled_Trial/links/60a10d2392851cfdf3389990/largepreview.png)
PDF) Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial
Effect of cyclosporin A on interleukin-6 and soluble interleukin-2 receptor in patients with rheumatoid arthritis. - Abstract - Europe PMC
![Ankylosing spondylitis measures: The Ankylosing Spondylitis Quality of Life (ASQOL) Scale, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS ... Ankylosing spondylitis measures: The Ankylosing Spondylitis Quality of Life (ASQOL) Scale, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS ...](https://onlinelibrary.wiley.com/cms/asset/99d2af37-44f4-4c64-a002-de474a8e45dc/art.11412.fp.png)